Trial
NCT00089284
Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHL
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Northwestern University
Collaborators
Robert H. Lurie Cancer Center
Condition
Non-Hodgkin's Lymphoma (NHL)
Intervention
Rituxan
Why stopped
Due to lack of funding, phase II of study was not completed.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-08-14